Cyclin D1 in breast premalignancy and early breast cancer: implications for prevention and treatment

被引：28
作者：
Zhou, Q
Hopp, T
Fuqua, SAW
Steeg, PS
机构：
[1] NCI, Womens Canc Sect, Pathol Lab, Div Clin Sci,NIH, Bethesda, MD 20892 USA
[2] Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA
来源：
CANCER LETTERS | 2001年 / 162卷 / 01期
关键词：
cyclin D; breast cancer; tumorigenesis; cell cycle; apoptosis; Apo-2; radiation; estrogen receptor; atypical ductal hyperplasia; ductal carcinoma in situ;
D O I：
10.1016/S0304-3835(00)00657-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3 / 17
页数：15
相关论文
共 106 条
  • [1] Cyclin D1 associates with the TBP-associated factor TAFII250 to regulate Sp1-mediated transcription
    Adnane, J
    Shao, ZH
    Robbins, PD
    [J]. ONCOGENE, 1999, 18 (01) : 239 - 247
  • [2] Alle KM, 1998, CLIN CANCER RES, V4, P847
  • [3] Amari M, 1999, ONCOL REP, V6, P1277
  • [4] ANZANO MA, 1994, CANCER RES, V54, P4614
  • [5] Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells
    Asano, K
    Sakamoto, H
    Sasaki, H
    Ochiya, T
    Yoshida, T
    Ohishi, Y
    Machida, T
    Kakizoe, T
    Sugimura, T
    Terada, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 217 (03) : 1169 - 1176
  • [6] Apoptosis induced in mammalian cells by small peptides that functionally antagonize the Rb-regulated E2F transcription factor
    Bandara, LR
    Girling, R
    LaThangue, NB
    [J]. NATURE BIOTECHNOLOGY, 1997, 15 (09) : 896 - 901
  • [7] p21(WAF1) immunohistochemical expression in breast carcinoma: Correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival
    Barbareschi, M
    Caffo, O
    Doglioni, C
    Fina, P
    Marchetti, A
    Buttitta, F
    Leek, R
    Morelli, L
    Leonardi, E
    Bevilacqua, G
    DallaPalma, P
    Harris, AL
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (02) : 208 - 215
  • [8] Cyclin D1 in breast cancer
    Barnes, DM
    Gillett, CE
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 1 - 15
  • [9] Ductal carcinoma in situ of the breast: Frequency of biomarkers according to histologic subtype
    Bhoola, S
    DeRose, PB
    Cohen, C
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 1999, 7 (02): : 108 - 115
  • [10] Boyages J, 1999, CANCER, V85, P616, DOI 10.1002/(SICI)1097-0142(19990201)85:3<616::AID-CNCR12>3.3.CO
12345678910